Short acting insulin analogues versus regular human insulin in patients with type 1 diabetes mellitus

Short acting insulin analogues versus regular human insulin in patients with type 1 diabetes mellitus is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Short acting insulin analogues versus regular human insulin in patients with type 1 diabetes mellitus ID - 450745 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450745/all/Short_acting_insulin_analogues_versus_regular_human_insulin_in_patients_with_type_1_diabetes_mellitus PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -